Andrew Udell
Plus aucun poste en cours
Fortune : 275 742 $ au 31/03/2024
Profil
Andrew B.
Udell worked as the President-North America Region at Calliditas Therapeutics AB from 2021 to 2024 and as the Vice President-North America Commercial at NeuroDerm Ltd.
from 2017 to 2018.
He completed his undergraduate degree at Lehigh University and earned an MBA from the University of Connecticut.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/02/2023 | 26 000 ( 0,04% ) | 275 742 $ | 31/03/2024 |
Anciens postes connus de Andrew Udell
| Sociétés | Poste | Fin |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 07/01/2024 |
| NEURODERM LTD | Corporate Officer/Principal | 01/06/2018 |
Formation de Andrew Udell
| Lehigh University | Undergraduate Degree |
| University of Connecticut | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
